Correspondence
Serum lactate is a poor marker of bowel ischemia following angioembolization for lower gastrointestinal bleeding
Digestive Medicine Research
2020;
3:
118
(30 December 2020)
Letter to the Editor
A difficult balance of priorities when choosing management of colon cancer with synchronous isolated liver metastases
Digestive Medicine Research
2020;
3:
117
(30 December 2020)
Letter to the Editor
Conventional vs. extended D2 lymphadenectomy in gastric cancer patients: less is more?—more or less
Digestive Medicine Research
2020;
3:
116
(30 December 2020)
Editorial Commentary
Immunotherapy in advanced hepatocellular carcinoma: an evolving space in the systemic treatment paradigm
Digestive Medicine Research
2020;
3:
115
(30 December 2020)
Editorial Commentary
Clinical significance of extracellular vesicles in plasma from pancreatic cancer patients
Digestive Medicine Research
2020;
3:
114
(30 December 2020)
Editorial Commentary
Prognostic value of microsatellite instability (MSI)/deficient mismatch repair (MMR) and BRAFV600E mutation in recurring stage III colon cancer: insights from an ACCENT pooled analysis of seven adjuvant chemotherapy trials
Digestive Medicine Research
2020;
3:
113
(30 December 2020)
Editorial Commentary
Assaying circulating-tumor DNA to predict recurrence of localized colon cancer
Digestive Medicine Research
2020;
3:
112
(30 December 2020)
Editorial Commentary
Statins for cirrhosis: almost ready for clinical application
Digestive Medicine Research
2020;
3:
111
(30 December 2020)
Editorial Commentary
Gastrointestinal oncology in the midst of the COVID-19 pandemic
Digestive Medicine Research
2020;
3:
110
(30 December 2020)
Editorial Commentary
The role of adjuvant therapy in the treatment of pT3N0 rectal cancer
Digestive Medicine Research
2020;
3:
109
(30 December 2020)
Editorial Commentary
Norursodeoxycholic acid as a candidate pharmacological therapy for nonalcoholic fatty liver disease
Digestive Medicine Research
2020;
3:
108
(30 December 2020)
Editorial Commentary
Anti-IL-15 monoclonal antibody for the treatment of coeliac disease: the light at the end of the gluten free diet tunnel?
Digestive Medicine Research
2020;
3:
107
(30 December 2020)
Editorial Commentary
Mounting evidence that anti-tumour necrosis factor-α therapy does not increase the risk of new or recurrent cancer
Digestive Medicine Research
2020;
3:
106
(30 December 2020)
Editorial Commentary
Neoadjuvant chemoradiation for resectable and borderline resectable pancreatic cancer: is there a benefit?
Digestive Medicine Research
2020;
3:
105
(30 December 2020)
Editorial Commentary
Hyperlipidemia with obeticholic acid in the treatment of nonalcoholic steatohepatitis
Digestive Medicine Research
2020;
3:
104
(30 December 2020)
Editorial Commentary
Neoadjuvant chemoradiotherapy is not superior to upfront surgery in pancreatic adenocarcinoma
Digestive Medicine Research
2020;
3:
103
(30 December 2020)
Editorial Commentary
Liberalizing transplantation of HCV positive donor organs into HCV negative recipients
Digestive Medicine Research
2020;
3:
102
(30 December 2020)
Editorial Commentary
Hyperbilirubinemia in gemcitabine plus nab-paclitaxel–treated patients with pancreatic cancer
Digestive Medicine Research
2020;
3:
101
(30 December 2020)
Editorial Commentary
Pembrolizumab and immunotherapy in advanced hepatocellular carcinoma: an evaluation of KEYNOTE-240
Digestive Medicine Research
2020;
3:
100
(30 December 2020)
Editorial Commentary
A significant difference between two randomized controlled trials to compare laparoscopic and open distal gastrectomy for early gastric cancer
Digestive Medicine Research
2020;
3:
99
(30 December 2020)
